NO172240C - Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2'-halometylidenderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2'-halometylidenderivater

Info

Publication number
NO172240C
NO172240C NO894539A NO894539A NO172240C NO 172240 C NO172240 C NO 172240C NO 894539 A NO894539 A NO 894539A NO 894539 A NO894539 A NO 894539A NO 172240 C NO172240 C NO 172240C
Authority
NO
Norway
Prior art keywords
halomethylendend
derivatives
preparation
therapeutically active
active new
Prior art date
Application number
NO894539A
Other languages
English (en)
Norwegian (no)
Other versions
NO172240B (no
NO894539D0 (no
NO894539L (no
Inventor
James Ray Mccarthy
Michael Louis Edwards
Donald Paul Matthews
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO894539D0 publication Critical patent/NO894539D0/no
Publication of NO894539L publication Critical patent/NO894539L/no
Publication of NO172240B publication Critical patent/NO172240B/no
Publication of NO172240C publication Critical patent/NO172240C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
NO894539A 1988-11-15 1989-11-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2'-halometylidenderivater NO172240C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27147988A 1988-11-15 1988-11-15

Publications (4)

Publication Number Publication Date
NO894539D0 NO894539D0 (no) 1989-11-14
NO894539L NO894539L (no) 1990-05-16
NO172240B NO172240B (no) 1993-03-15
NO172240C true NO172240C (no) 1993-06-23

Family

ID=23035764

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894539A NO172240C (no) 1988-11-15 1989-11-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2'-halometylidenderivater

Country Status (19)

Country Link
EP (1) EP0372268B1 (de)
JP (1) JP2802947B2 (de)
KR (1) KR0144865B1 (de)
CN (1) CN1022248C (de)
AR (1) AR247891A1 (de)
AT (1) ATE105297T1 (de)
AU (1) AU621160B2 (de)
CA (1) CA2002648C (de)
DE (1) DE68915128T2 (de)
DK (1) DK171844B1 (de)
ES (1) ES2056180T3 (de)
FI (1) FI92588C (de)
HU (3) HU205134B (de)
IE (1) IE63563B1 (de)
IL (1) IL92293A (de)
NO (1) NO172240C (de)
NZ (1) NZ231365A (de)
PT (1) PT92309B (de)
ZA (1) ZA898567B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US5047520A (en) * 1987-03-19 1991-09-10 Yamasa Shoyu Kabushiki Kaisha 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof
IE902574A1 (en) * 1989-07-17 1991-02-27 Univ Birmingham Antiviral pyrimidine nucleosides
US5521163A (en) * 1990-07-13 1996-05-28 University Of Birmingham Antiviral pyrimidine nucleosides and methods for using same
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
WO1993022327A1 (fr) * 1992-04-23 1993-11-11 Yoshitomi Pharmaceutical Industries, Ltd. Compose de 2'-methylidenenucleoside et utilisation pharmaceutique de ce compose
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
EP0640092B1 (de) * 1992-05-12 1996-12-11 Merrell Pharmaceuticals Inc. Verfahren zur herstellung von ribonukleotid-reduktasehemmern
CA2150671C (en) * 1992-12-03 2000-12-26 Sai P. Sunkara Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections
ATE186732T1 (de) * 1994-01-07 1999-12-15 Merrell Pharma Inc (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydr t
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
EP0770621A4 (de) * 1994-07-12 1998-01-28 Yamasa Corp 2'-deoxy-2'(substituiertes oder unsubstituiertes methylidene)-4-thionukleosid
EP1438054A4 (de) * 2001-09-28 2006-07-26 Idenix Cayman Ltd Verfahren und zusammensetzungen zur behandlung von flaviviren und pestiviren mit 4'-modifiziertem nucleosid
WO2003068162A2 (en) * 2002-02-14 2003-08-21 Pharmasset Ltd. Modified fluorinated nucleoside analogues
KR20040036417A (ko) * 2002-10-25 2004-04-30 정낙신 항암 활성을 갖는 티오뉴클레오시드 유도체 및 이를함유하는 약학적 조성물
CN100389119C (zh) * 2004-10-27 2008-05-21 北京东华康明生物科技有限公司 （反式）-2-脱氧-2-（氟亚甲基）-4-r酰胞苷化合物及其制备方法
SG10201610936RA (en) 2011-12-22 2017-02-27 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2014078463A1 (en) * 2012-11-19 2014-05-22 Merck Sharp & Dohme Corp. 2 -alkynyl substituted nucleoside derivatives for treating viral diseases
WO2018092107A1 (en) * 2016-11-21 2018-05-24 Munisekhar Medasani Novel anti-viral and anti-cancer molecule

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047520A (en) * 1987-03-19 1991-09-10 Yamasa Shoyu Kabushiki Kaisha 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof

Also Published As

Publication number Publication date
AU4461189A (en) 1990-05-24
JPH02178272A (ja) 1990-07-11
IL92293A0 (en) 1990-07-26
HU00045A9 (en) 1995-01-30
KR0144865B1 (ko) 1998-07-01
KR900007833A (ko) 1990-06-02
HUT51642A (en) 1990-05-28
DK171844B1 (da) 1997-06-30
CN1022248C (zh) 1993-09-29
HU210343A9 (en) 1995-03-28
PT92309A (pt) 1990-05-31
IL92293A (en) 1995-01-24
DE68915128D1 (de) 1994-06-09
NO172240B (no) 1993-03-15
NO894539D0 (no) 1989-11-14
AR247891A1 (es) 1995-04-28
NZ231365A (en) 1992-08-26
DK570089D0 (da) 1989-11-14
HU895900D0 (en) 1990-02-28
CA2002648A1 (en) 1990-05-15
IE893651L (en) 1990-05-15
FI895417A0 (fi) 1989-11-14
NO894539L (no) 1990-05-16
CN1042715A (zh) 1990-06-06
EP0372268B1 (de) 1994-05-04
DK570089A (da) 1990-05-16
ZA898567B (en) 1990-08-29
JP2802947B2 (ja) 1998-09-24
AU621160B2 (en) 1992-03-05
FI92588C (fi) 1994-12-12
EP0372268A1 (de) 1990-06-13
DE68915128T2 (de) 1994-08-25
PT92309B (pt) 1996-06-28
ATE105297T1 (de) 1994-05-15
IE63563B1 (en) 1995-05-17
FI92588B (fi) 1994-08-31
ES2056180T3 (es) 1994-10-01
HU205134B (en) 1992-03-30
CA2002648C (en) 2000-02-29

Similar Documents

Publication Publication Date Title
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO170023C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive alfa-glucosidaseinhibitorer
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO914667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO894539D0 (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
NO168361C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye adenosinderivater
NO172849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO172539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO173607C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive tienotriazolo-diazepin-derivater
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater

Legal Events

Date Code Title Description
MK1K Patent expired